These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6373315)

  • 1. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics.
    Felsing W; Bibergeil H; Menzel R; Albrecht G; Felsing U; Dabels J; Reichel G; Lüder C
    Exp Clin Endocrinol; 1984 Apr; 83(2):136-42. PubMed ID: 6373315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral nerve function and metabolic control in diabetes mellitus.
    Troni W; Carta Q; Cantello R; Caselle MT; Rainero I
    Ann Neurol; 1984 Aug; 16(2):178-83. PubMed ID: 6383190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
    Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
    Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of intensified insulin therapy.
    Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
    Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor conduction velocity (MCV) in insulin-dependent and non-insulin-dependent diabetics with and without clinical peripheral neuropathy.
    Fedele D; Negrin P; Fardin P; Tiengo A
    Diabete Metab; 1980 Sep; 6(3):189-92. PubMed ID: 7439492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of cardiovascular autonomic reflexes after amelioration of metabolic control in insulin-dependent diabetic subjects with severe autonomic neuropathy.
    Fedele D; Bellavere F; Cardone C; Ferri M; Crepaldi G
    Horm Metab Res; 1985 Aug; 17(8):410-3. PubMed ID: 4054829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous subcutaneous insulin infusion: long-term treatment in an unselected group of insulin-dependent diabetics].
    Waldhäusl W; Freyler H; Bratusch-Marrain P; Vierhapper H; Bruneder H
    Dtsch Med Wochenschr; 1983 Apr; 108(15):570-7. PubMed ID: 6404620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Catheter-pens"--an alternative to insulin pump treatment?
    Menzel R; Chlup R; Jutzi E; Hildmann W
    Exp Clin Endocrinol; 1990 Feb; 95(1):157-69. PubMed ID: 2335181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function in type I diabetes mellitus.
    Warmolts JR; Mendell JR; O'Dorisio TM; Cataland S
    J Neurol Sci; 1987 Dec; 82(1-3):161-9. PubMed ID: 3326911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.
    Service FJ; Rizza RA; Daube JR; O'Brien PC; Dyck PJ
    Diabetologia; 1985 Oct; 28(10):722-7. PubMed ID: 3905469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained normoglycemia and remission phase in newly diagnosed type I diabetic subjects. Comparison between continuous subcutaneous insulin infusion and conventional therapy during a one year follow-up.
    Edelmann E; Walter H; Biermann E; Schleicher E; Bachmann W; Mehnert H
    Horm Metab Res; 1987 Sep; 19(9):419-21. PubMed ID: 3319859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.